The Long-term Costs of a Short-term 503B
503B facilities play a key role in healthcare today. Find out about the unseen costs for hospitals and patients when a 503B partner exits the market.
Secure your 503B supply: SCA Pharma on Medigi
Secure your 503B supply with SCA Pharma and Medigi Supply chain disruptions keep pharmacy leaders awake at night. When unexpected market shifts threaten your access to essential medications, patient safety hangs in the balance. You need a reliable 503B outsourcing partner to step in and fill those crucial inventory gaps immediately. SCA Pharma offers healthcare…
The Strategic Advantage of Streamlining the Pharmacy Supply Chain
Building a Resilient and Efficient Pharmacy Operation As a pharmacy leader, you stand at the critical intersection of clinical excellence and financial stewardship. Each day brings the challenge of ensuring patient safety while navigating complex budgets and operational hurdles. In this demanding environment, the structure of your pharmacy supply chain is not just a logistical…
SCA Pharma Expands Access: Core Pharmaceutical Products Now Available on Additional Platforms
As part of our ongoing commitment to reliability, accessibility, and quality in the healthcare supply chain, SCA Pharma is pleased to announce an expanded distribution approach for our core pharmaceutical products. Healthcare professionals can now access SCA Pharma’s trusted offerings through a broader network of purchasing platforms, including Medigi as an alternate location. This important…
Understanding Product Development in 503B Outsourcing Facilities
Product development in 503B outsourcing facilities involves a detailed, highly regulated process. Every compounded medication produced by facilities like SCA Pharma must be safe, compliant, and aligned with the needs of healthcare institutions. This blog dives deeper into the product development process, covering each phase from discovery to post-launch monitoring. The Product Development Process The development…
Buy and Ship Now supports access to critical medications
In the fast-paced healthcare environment, access to critical medications is essential for providing timely, effective patient care. Ensuring the right medications are on hand when needed can be a logistical challenge for hospital pharmacies. This is where a reliable 503B outsourcing facility offering a “Buy & Ship Now” option becomes invaluable. By allowing hospital pharmacies…
Hospital Pharmacies Planning Ahead Now For Rise In Elective Surgeries
Last winter, as the US hospital system became overwhelmed with COVID-19 cases related to the Omicron strain, facilities across the country were forced to postpone elective surgeries to free up hospital beds. Similar to what happened following the initial outbreak of the pandemic in 2020, patients are now returning to the operating room to have…
FDA Announces Glycopyrrolate Will Not Be Included on 503B Bulks List
On January 27, 2022, the FDA announced its decision to not include Glycopyrrolate on the 503B bulks list. Following this announcement, outsourcing facilities will not be permitted to compound the drug-using bulk API, unless the product appears in the future on the FDA’s drug shortage list. Glycopyrrolate is not currently on the drug shortage list.…
SCA Pharma extends Beyond Use Dating on many products
SCA Pharma’s customers have requested extended Beyond Use Dating (BUD), and we are pleased to help meet their needs by extending BUDs on 69 products to date, while still maintaining our stringent quality controls. We anticipate extending BUDs on most or all of our products. Beyond Use Dating (BUD) on compounded sterile preparations is important…
The indirect costs of risk management for hospital insourcing
This post is our third in a series of blogs looking at how hospitals make the difficult decision to compound their own drugs versus selecting an outsourcing partner. The decision involves a great deal more than a clean room and a vial of medication. A wide range of indirect costs are specifically related to risk…